glycoprotein
inhibit
glycosyl
tunicamycin
deoxyglucos
glucosamin
dolichol
pathway
glycosyl
mani
virus
pathogen
man
anim
possess
surfac
membran
viral
envelop
although
signific
differ
number
arrang
envelop
constitu
occur
sever
featur
membran
structur
share
virus
includ
presenc
lipid
bflayer
glycosyl
protein
expos
extern
surfac
bilay
glycoprotein
usual
present
form
spike
nm
length
glycoprotein
amphipath
molecul
consist
extern
hydrophil
part
hydrophob
segment
spike
strongli
associ
lipid
bflayer
review
see
compan
klenk
gener
accept
viru
spike
play
import
role
interact
viral
envelop
cellular
membran
primari
biolog
function
initi
infect
cellular
level
probabl
shown
best
orthoand
paramyxovirus
specif
role
play
viral
glycoprotein
adsorpt
penetr
quit
well
understood
also
demonstr
glycoprotein
virus
import
determin
spread
infect
thu
pathogen
review
see
klenk
et
al
anoth
import
aspect
function
viral
glycoprotein
host
defens
major
surfac
antigen
usual
target
neutral
antibodi
viral
glycoprotein
studi
date
contain
oligosaccharid
side
chain
attach
nglycosid
linkag
polypeptid
glycoprotein
includ
among
other
hemagglutinin
neuraminidas
influenza
virus
hemagglutininneuraminidas
fusion
protein
paramyxovirus
glycoprotein
semliki
forest
viru
sindbi
viru
vesicular
stomat
viru
review
see
compan
klenk
glycoprotein
oglycosid
linkag
far
rare
observ
virus
glycoprotein
recent
character
coronavirus
present
togeth
anoth
glycoprotein
nglycosid
type
biosynthesi
viral
glycoprotein
nglycosid
linkag
studi
detail
involv
translat
membranebound
ribosom
insert
membran
rough
endoplasm
reticulum
transport
site
viru
assembl
usual
plasma
membran
cours
transport
glycoprotein
process
glycosyl
proteolyt
cleavag
coval
bind
fatti
acid
cotransl
level
proteolyt
cleavag
mani
instanc
remov
signal
sequenc
requir
insert
nascent
polypeptid
membran
rough
endoplasm
reticulum
posttransl
cleavag
involv
process
seri
glycoprotein
influenza
hemagglutinin
glycoprotein
paramyxovirus
alphavirus
oncovirus
case
myxoviru
glycoprotein
posttransl
proteolyt
cleavag
found
precondit
biolog
activ
review
see
klenk
rott
biosynthesi
glycoprotein
inhibit
interf
intraceuular
transport
proteolyt
cleavag
glycosyl
articl
confin
inhibit
glycosyl
date
glycosyl
inhibitor
interf
biosynthesi
nglycosidicauy
link
oligosaccharid
known
thu
observ
made
glycoprotein
contain
type
side
chain
review
oligosaccharid
side
chain
viral
glycoprotein
assembl
biosynthet
machineri
host
cell
gener
principl
carbohydr
cellular
glycoprotein
glycosyl
glycoprotein
nglycosid
linkag
initi
rough
endoplasm
reticulum
attach
preform
oligosaccharid
asparagin
residu
polypeptid
chain
attach
site
sequenc
asparaginexthreonin
asparaginexserin
x
variabl
amino
acid
oligosaccharid
transfer
nascent
polypeptid
synthes
via
dolichol
pathway
glycosyl
recent
review
detail
elsewher
summar
follow
fig
carbohydr
chain
assembl
phosphat
ester
isoprenoid
alcohol
dolichol
udpnacetylglucosamin
gdpmannos
mannosylphosphoryldolichol
glucosylphosphoryldolichol
sugar
donor
en
bloc
transfer
oligosaccharid
polypeptid
cleavag
pyrophosph
linkag
doliehol
phosphat
avail
new
assembl
cycl
oligosaccharid
synthes
way
usual
tetradecasaccharid
structur
glucosyl
mannosyl
nacetylglucosamin
certain
condit
describ
decasaccharid
structur
glucosyl
mannosyl
nacetylglucosamin
transfer
glycosylatinn
via
decasaccharid
lipid
call
altern
pathway
enzym
involv
assembl
lipidlink
oligosaccharid
membranebound
appear
occur
mainli
rough
endoplasm
reticulum
discuss
see
schwarz
datema
transfer
polypeptid
oligosaccharid
side
chain
process
fig
first
three
glucos
residu
remov
specif
glucosidas
yield
mannoserich
carbohydr
side
chain
stage
process
oligosaccharid
may
ceas
instanc
howev
continu
trim
process
result
releas
mannos
three
subsequ
addit
nacetylglucosamin
galactos
fucos
neuramin
acid
complex
oligosaccharid
form
avail
evid
indic
enzym
involv
last
step
glycosyl
sequenc
locat
golgi
apparatu
review
see
klenk
rott
tein
type
deriv
common
precursor
also
evid
said
number
posit
oligosaccharid
polypeptid
determin
presenc
appropri
amino
acid
sequenc
act
attach
site
number
side
chain
attach
differ
glycoprotein
vari
therefor
wide
rang
eg
g
protein
vesicular
stomat
viru
two
oligosaccharid
wherea
mani
seven
side
chain
observ
influenza
hemaggiutinin
studi
influenza
hemagglutinin
reveal
also
mani
variant
glycoprotein
vari
wide
distribut
glycosyl
site
oligosaceharid
type
attach
result
indic
structur
polypeptid
play
import
role
determin
whether
mannosetich
complex
oligosaccharid
attach
given
glycosyl
site
despit
high
variabl
glycosyl
site
hemagglutinin
appear
conserv
interest
note
accord
threedimension
model
hemagglutinin
conserv
side
chain
locat
close
vicin
base
spike
may
indic
side
chain
special
function
maintain
proper
implant
glycoprotein
lipid
bilay
recent
year
varieti
substanc
discov
interfer
biosynthesi
envelop
virus
tabl
includ
among
other
dglucosamin
tunicamycin
first
viru
demonstr
substanc
specif
interfer
glycosyl
influenza
viru
presenc
inhibitor
unglycosyl
form
viral
hemagglutinin
could
identifi
inhibitor
glycosyl
becam
therefor
valuabl
tool
studi
role
carbohydr
moieti
biosynthesi
function
viral
glycoprotein
substanc
interfer
assembl
dolichollink
oligosaccharid
littl
known
inhibitor
interf
transfer
polypeptid
process
proteinbound
differ
step
glycol
occur
differ
cell
compart
inhibitor
intracellular
transport
review
see
tartakoff
indirectli
interfer
process
follow
mode
action
glycosyl
interf
viru
multipl
briefli
discuss
inform
reader
refer
comprehens
review
latter
two
deal
also
glycosyl
inhibitor
bacitracin
amphomycin
showdomycin
diumycin
far
found
activ
intact
anim
cell
sugar
analogu
readili
metabol
cell
metabolit
name
udpdeoxyglucos
gdpdeoxyglucos
deoxyglucosylphosphoryldolichol
actual
inhibitori
agent
reaction
dolichol
cycl
inhibit
udpdeoxyglucos
format
glucosylphosphoryldolichol
fig
gdpdeoxyglucos
appear
import
inhibitori
metabolit
interfer
format
dolichollink
monosaccharid
trap
phosphoryldolichol
deoxyglucosylphosphoryldolichol
assembl
lipidlink
oligosaccharid
incorpor
deoxyglucos
instead
mannos
deoxyglucosylphosphoryldolichol
interfer
also
format
lipidbound
oligosaccharid
replac
glucos
deoxyglucos
studi
cellfre
system
shown
lipidlink
oligosaccharid
contain
deoxyglucos
transfer
polypeptid
hand
also
shown
noninhibitori
condit
deoxyglucos
incorpor
glycoprotein
appar
discrep
understood
obviou
fmding
deoxyglucos
act
primarili
analogu
mannos
therefor
surpris
inhibitori
action
revers
mannos
fluoroglucos
interfer
mannosyl
reaction
inhibit
format
mannosylphosphoryldolichol
therefor
block
assembl
lipidbound
tetradecasaccharid
inhibit
assembl
revers
prevent
mannos
interest
note
presenc
fluoroglucos
altern
pathway
glycosyl
inhibit
thu
decasaccharid
shown
fig
still
transfer
protein
studi
effect
protein
glycosyl
uncoupl
oxid
phosphoryl
shown
glycosyl
via
altern
pathway
uniqu
featur
fluoroglucos
cell
infect
influenza
viru
treat
cccp
endoglucosaminidas
hresist
mannosetich
intermedi
altern
pathway
found
viral
glycoprotein
oligosaccharid
process
complex
form
energi
deplet
cccp
decreas
migrat
rate
glycoprotein
golgi
system
investig
metabol
glucosamin
condit
inhibit
protein
glycosyl
reveal
unusu
metabolit
intracellular
concentr
glucosamin
strongli
increas
incub
glucosaminefre
medium
rapidli
revers
inhibit
glycosyl
revers
intracellular
concentr
glucosamin
metabolit
decreas
therefor
deduc
glucosamin
inhibitor
protein
glycosyl
subsequ
studi
shown
glucosamin
inhibit
earli
step
assembl
lipidlink
oligosaccharid
lipidbound
oligosaccharid
reduc
sugar
content
detect
datema
schwarz
unpublish
result
howev
exact
mechan
action
yet
clear
nucleosid
antibiot
streptomyc
lysosuperificu
tightbind
competit
inhibitor
enzym
transfer
phosphorylnacetylglucosamin
udpnacetylglucosamin
phosphoryldolichol
therefor
inhibit
format
nacetylglucosaminylpyrophosphoryldolichol
howev
rel
high
concentr
tunicamycin
need
achiev
inhibit
glycosyl
exampl
human
fibroblast
effect
tunicamycin
inhibit
glucosylphosphoryldolichol
format
inhibit
protein
synthesi
may
becom
import
compound
found
inhibit
glycosyl
herp
viru
glycoprotein
earli
step
exact
mode
action
unknown
point
alreadi
substanc
interfer
glycosyl
glycoprotein
contain
nglycosid
linkag
therefor
use
differenti
glycoprotein
glycoprotein
side
chain
synthes
via
pathway
use
approach
possibl
demonstr
exampl
coronaviru
glycoprotein
oglycosid
linkag
wherea
glycoprotein
nglycosid
linkag
gener
assum
carbohydr
side
chain
influenc
biolog
properti
glycoprotein
either
determ
conform
molecul
less
like
directli
particip
reaction
exampl
oligosaecharid
side
chain
influenza
hemaggiutinin
locat
surfac
spike
remov
carbohydr
might
therefor
factilit
access
ofproteolyt
enzym
shown
inde
case
alreadi
point
substanti
portion
carbohydr
close
membran
may
necessari
proper
implant
spike
lipid
remov
carbohydr
may
therefor
disturb
intraceuular
transport
part
carbohydr
locat
distal
end
hemagglutinin
close
antigen
site
neuramin
acid
bind
site
may
therefor
contribut
interact
hemagglutinin
antibodi
cell
receptor
follow
brief
review
given
biolog
effect
observ
inhibit
glycosyl
differ
viru
system
point
mask
potenti
cleavag
site
oligosaccharid
may
contribut
specif
cleavag
pattern
glycoprotein
therefor
surpris
presenc
deoxyglucos
glucosamin
cleavag
nonglycosyl
precursor
hao
influenza
viru
hemagglutinin
gave
heterogen
product
expect
howev
chick
embryo
cell
infect
viru
treat
tunicamycin
neither
hao
cleavag
product
could
detect
unless
proteas
inhibitor
ad
prevent
degrad
hao
differ
sugar
analogu
tunicamycin
effect
proteolyt
stabil
nonglycosyl
hemagglutinin
understood
point
difficult
make
gener
nakamura
compan
found
nonglycosyl
form
hemagglutinin
synthes
presenc
tunicamycin
without
proteas
inhibitor
could
detect
smooth
membran
differ
strain
influenza
viru
studi
differ
host
cell
unglycosyl
glycoprotein
semliki
forest
viru
sindbi
viru
vesicular
stomat
viru
also
appear
stabl
cell
seem
quit
clear
cotransl
glycosyl
requir
membran
insert
glycoprotein
indic
observ
presenc
glycosyl
inhibitor
influenza
viru
hemagglutinin
incorpor
rough
endoplasm
reticulum
found
cytoplasm
free
ribosom
studi
vitro
system
also
shown
glycoprotein
semliki
forest
viru
incorpor
membran
presenc
tunicamydn
unglycosyl
influenza
viru
hemagglutinin
transport
rough
endoplasm
reticulum
plasma
membran
manner
glyeosyl
compound
studi
effect
tunicamycin
g
protein
indiana
strain
vesicular
stomat
viru
shown
molecul
correct
conform
intracellular
transport
carbohydr
side
chain
present
howev
carbohydratefre
g
protein
orsay
strain
viru
transport
certain
condit
thu
case
carbohydratefre
glycoprotein
acquir
correct
conform
transport
observ
taken
togeth
indic
carbohydr
may
may
involv
intracellular
transport
viral
glycoprotein
furthermor
data
suggest
depend
amino
acid
sequenc
glycoprotein
whether
glycosyl
requir
clear
effect
glycosyl
inhibitor
stabil
intracellular
transport
viral
glycoprotein
describ
previou
section
consequ
viru
assembl
thu
assembl
semliki
forest
sindbi
virion
take
place
presenc
tunicamycin
deoxyglucos
transport
glycoprotein
block
condit
case
fowl
plaqu
viru
proteolyt
degrad
glycoprotein
synthes
presenc
tunicamycin
appear
reason
failur
viru
matur
howev
wsn
strain
influenza
viru
particl
lack
hemagglutinin
assembl
glycosyl
inhibit
tunicamycin
similarli
rou
sarcoma
virion
without
spike
produc
presenc
tunicamycin
knowledg
role
antigen
play
carbohydr
viral
glycoprotein
quit
fragmentari
conceiv
side
chain
act
antigen
site
commonli
assum
indirect
effect
antigen
influenc
conform
whole
glycoprotein
molecul
latter
concept
support
studi
carri
semliki
forest
viru
show
antigen
site
expos
unglycosyl
glycoprotein
synthes
presenc
glycosyl
inhibitor
site
cryptic
glycosyl
analogu
presenc
glycosyl
inhibitor
hemagglutin
neurarninidas
activ
drastic
reduc
infect
cell
even
though
unglycosyl
glycoprotein
made
fusion
activ
exert
paramyxovirus
herp
simplex
viru
also
depend
glycosyl
viral
glycoprotein
surpris
viru
particl
contain
glycoprotein
devoid
carbohydr
lack
glycoprotein
complet
synthesi
presenc
glycosyl
inhibitor
reduc
infect
shown
influenza
viru
herp
simplex
viru
rou
sarcoma
viru
differ
result
howev
obtain
vesicular
stomat
viru
particl
contain
unglycosyl
glycoprotein
specif
infect
similar
normal
particl
thu
instanc
lack
carbohydr
appear
littl
effect
biolog
activ
glycoprotein
despit
fact
sever
glycosyl
inhibitor
present
known
mani
year
littl
known
clinic
use
substanc
knowledg
two
studi
exist
concern
herp
viru
infect
instanc
deoxyglucos
use
first
studi
herp
simplex
viru
infect
rabbit
eye
treat
sugar
analogu
found
effect
prevent
reduc
sever
herpet
kerat
topic
subconjunctiv
administr
deoxyglucos
efficaci
toxic
effect
observ
topic
appli
deoxyglucos
penetr
cornea
aqueou
compart
ciliari
bodi
vitreou
retina
infect
eye
least
fivefold
increas
specif
activ
sugar
analogu
obtain
herp
simplex
viru
infect
compar
uninfect
scarifi
control
second
studi
concern
treatment
human
genit
herp
infect
thirtysix
women
treat
doubleblind
placebocontrol
studi
period
week
medic
appli
topic
initi
case
cure
two
recurr
month
case
recurr
secondari
infect
notabl
improv
initi
infect
discomfort
clear
within
h
therapi
conclud
use
deoxyglucos
provid
simpl
uniqu
approach
treatment
genit
herp
viru
infect
glycosyl
viral
glycoprotein
nglycosid
linkag
inhibit
number
substanc
differ
chemic
natur
gener
compound
interfer
synthesi
dolicholbound
precursor
carbohydr
side
chain
molecular
virolog
glycosyl
inhibitor
becam
standard
tool
analysi
structur
biosynthesi
function
viral
glycoprotein
although
difficult
establish
unifi
concept
role
carbohydr
viral
glycoprotein
evid
obtain
experi
glycosyl
inhibitor
oligosaccharid
may
necessari
resist
glycoprotein
proteolyt
degrad
express
biolog
function
format
antigen
site
intracellular
transport
glycoprotein
format
infecti
viru
particl
glycosyl
inhibitor
prove
also
use
agent
differentl
viral
glycoprotein
nglycosid
oglycosid
linkag
emphas
glycosyl
viral
cellular
glycoprotein
follow
metabol
pathway
inhibitor
glycosyl
specif
antivir
drug
use
therapeut
agent
appear
therefor
restrict
viral
infect
drug
appli
topic
demonstr
success
treatment
ocular
genit
herp
simplex
viru
infect
deoxyglucos
